RVMD
Revolution Medicines Inc
199.90$
+4.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +109.5% | -7.4% | -5.2% | -2.5% | +45.1% | -7.5% | +2.7% | -7.3% | +4.6% | -4.3% | +91.8% | |
| – | +127.9% | -8.0% | -6.0% | -2.8% | +47.4% | -8.3% | +2.0% | -9.1% | +4.9% | -5.2% | +104.7% | |
| – | +94.2% | -58.6% | -4.4% | -27.0% | +169.8% | -38.6% | +20.7% | -46.0% | +76.5% | +14.9% | +84.9% | |
| – | +127.9% | -8.1% | -6.6% | -2.6% | +47.7% | -8.2% | +1.6% | -9.6% | +4.9% | -5.8% | +106.4% | |
| – | +305.8% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.5% | -0.1% | +0.0% | +0.0% | |
| – | +60.5% | -22.3% | +3.7% | +3.7% | +49.0% | -2.0% | +96.4% | +16.1% | +10.4% | +4.2% | +127.8% | |
| – | +68.2% | -34.8% | +12.4% | +5.3% | +47.9% | -3.2% | +16.4% | +33.1% | +18.2% | -0.3% | +22.3% | |
| – | +28.0% | +10.9% | +2.0% | +0.8% | +53.3% | +0.8% | +0.8% | +24.7% | +0.9% | +0.9% | +0.9% | |
| – | +108.6% | -47.6% | -9.5% | -16.6% | +122.6% | -12.7% | +19.5% | +31.9% | -13.7% | +24.6% | +9.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +118.1% | -5.5% | -6.2% | -3.2% | +44.6% | -8.3% | -10.2% | -14.4% | +2.2% | -8.1% | +73.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +29.3% | +16.7% | +0.3% | +1.0% | +0.5% | +12.2% | 0.0% | +0.6% | +0.5% | +4.2% | +6.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.